Time to shine PTX, page-16

I'm not sure we are talking about exactly the same TCN-P drug as indicated in the previous studies?

I’m no bio chemist however:-

Reference articles TCN-P triciribine (tricyclic nucleoside phosphate)

PTX-200 / TCN-P (triciribine phosphate monohydrate)

From what I understand & mentioned at the AGM is that PTX-200 has been 10 years in development at a cost of over 10 million dollars spent perfecting it in the lab to what it is today.

Only time will tell how successful the new/ revised drug will be as a combination therapy, & like everyone eagerly awaiting a market update on the current 1b/2 trials.